Concomitant Surgical Procedures and Aspirin Avoidance With Left Ventricular Assist Device Therapy

Thrombosis and Stroke

Trade-Off Between Bleeding and Ischemic Events From Left Ventricular Assist Devices: A EUROMACS Registry Analysis

J Am Coll Cardiol

Gallone G, Baldetti L, Veen KM, Bernhardt AM, Caliskan K, Fiane A, Najjar E, Netuka I, Özbaran M, Pya Y, Scandroglio AM, Spitaleri A, Sangiorgi D, Zimpfer D, Färber G, Gummert J, Meyns B, de By TMMH, Schoenrath F, De Ferrari GM, Rinaldi M, Potapov E, Loforte A

doi: 10.1016/j.jacc.2025.07.054

Heart, Artery and Coronary Diseases

Decreased Left Ventricular Systolic Function during the Late Phase after Response to Cardiac Resynchronization Therapy

Heart Rhythm

Iwawaki T, Inden Y, Yanagisawa S, Miyamae K, Miyazawa H, Goto T, Kondo S, Tachi M, Shimojo M, Tsuji Y, Murohara T

doi: 10.1016/j.hrthm.2025.02.002

Therapy and Intervention

Outcomes for Children With Congenital Heart Disease Undergoing Ventricular Assist Device Implantation: An ACTION Registry Analysis

J Am Coll Cardiol

Amdani S, Shezad MF, Kroslowitz B, Townsend M, Joong A, Najm H, Marino BS, Rosenthal DN, Lorts A, O'Connor MJ

doi: 10.1016/j.jacc.2024.10.083

Heart Failure

Real-life implementation of guideline-recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE-HF

Eur J Heart Fail

Malgie J, Wilde MI, Koudstaal S, Denham R, da Fonseca CA, Swart HP, van Ofwegen CEE, Yilmaz A, Pisters R, Linssen GCM, Faber N, van Heerebeek L, van de Swaluw JEC, de Boer RA, Brunner-La Rocca HP, Brugts JJ

doi: 10.1002/ejhf.70006

Heart Failure

The risk of death according to left ventricular ejection fraction and right ventricular dilatation in 17 321 adults with heart failure from 40 high-, middle- and low-income countries - A Global Congestive Heart Failure (G-CHF) study

Eur J Heart Fail

Leong DP, Joseph PG, Dokainish H, Störk S, McMurray JVV, Mielniczuk LM, Sharma SK, Orlandini A, Karaye KM, Bayes-Genis A, McCready T, Grinvalds A, Balasubramanian K, Branch KR, Kragholm K, Yusuf S, on behalf of the G‐CHF Investigators

doi: 10.1002/ejhf.3550

Atrial Fibrillation

Left Ventricular Ejection Fraction Response After Atrial Fibrillation Ablation: Clinical Predictors and Development of the PACED Score

Heart Rhythm

Al-Aidarous S, Rajappan S, Ahluwalia N, Uy CP, Abdelgawad H, Horrach CV, Kouadria S, Hua Z, Sandhar G, Cooke T, Rasheed S, Geran S, Chiew K, Lehri M, Palaiologos D, Khalil A, Kennedy B, Balasubramaniam R, Hussain S, Stanton L, Ahsan S, Primus CP, Chow A, Thomas M, Muthumala A, Ma Sohaib S, Ang R, Papageorgiou N, Butcher C, Rajappan K, Roney C, Hunter RJ, Honarbakhsh S

doi: 10.1016/j.hrthm.2025.11.039

Therapy and Intervention

Single versus Dual Antiplatelet Therapy after Left Atrial Appendage Closure: a Propensity Score Matching Analysis

Heart Rhythm

Galea R, Krsnik JP, Bini T, Chalkou K, Gasys A, Brugger N, Madhkour R, Seiffge DJ, Roten L, Siontis GCM, Räber L

doi: 10.1016/j.hrthm.2024.12.007

Atrial FibrillationTherapy and Intervention

Rationale and design of the Anticoagulant Therapy after Left Atrial Appendage Closure (ATLAAC) Trial

Am Heart J

Gosvig K, Goller J, Hansson NH, Brandes A, Modrau I, Rasmussen LF, Eskesen K, Jensen AKG, Belley-Côté E, Whitlock R, Riber LPS

doi: 10.1016/j.ahj.2025.04.015

Cardiovascular Risk and Diseases

Antiplatelet therapy with clopidogrel versus aspirin in atherosclerotic cardiovascular disease: a systematic review and meta-analysis

Atherosclerosis

Tscharre M, Mutschlechner D, Huber K, Gremmel T

doi: 10.1016/j.atherosclerosis.2025.120478

Related content

Trade-Off Between Bleeding and Ischemic Events From Left Ventricular Assist Devices: A EUROMACS Registry Analysis

Decreased Left Ventricular Systolic Function during the Late Phase after Response to Cardiac Resynchronization Therapy

Outcomes for Children With Congenital Heart Disease Undergoing Ventricular Assist Device Implantation: An ACTION Registry Analysis

Real-life implementation of guideline-recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE-HF

The risk of death according to left ventricular ejection fraction and right ventricular dilatation in 17 321 adults with heart failure from 40 high-, middle- and low-income countries - A Global Congestive Heart Failure (G-CHF) study

Left Ventricular Ejection Fraction Response After Atrial Fibrillation Ablation: Clinical Predictors and Development of the PACED Score

Single versus Dual Antiplatelet Therapy after Left Atrial Appendage Closure: a Propensity Score Matching Analysis

Rationale and design of the Anticoagulant Therapy after Left Atrial Appendage Closure (ATLAAC) Trial

Antiplatelet therapy with clopidogrel versus aspirin in atherosclerotic cardiovascular disease: a systematic review and meta-analysis